FDA Issues 43 Product-Specific Guidances
Comprises 33 New Guidances And 10 Revised Documents
The latest update from the FDA has brought 43 new and updated product-specific guidances for generic drug development, including dedicated documents on complex generics such as aerosols, powders and sprays.
You may also be interested in...
Carbogen Amcis, LGM Pharma, Vetter and PCI Pharma are focusing on expanding their businesses, while ChemWerth has filed its 500th drug master file for clevidipine with the FDA.
The FDA has issued 69 product-specific guidances for generic drug development, comprising 26 new guidances and 43 revised documents.
Given the challenges faced by complex generics, GDUFA-funded research is attempting to provide data to help assess and approve ANDAs for complex generic products.